MAS vs PACB · P/E 18, rev $7.83B vs rev $38.4M
Masco Corporation (MAS) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. PACB currently screens at market cap $387.1M.
Not investment advice. Open the MAS and PACB stock pages for the full models.
Not investment advice.